FIELD: pharmaceutics.
SUBSTANCE: invention relates to the field of pharmaceutics, namely to a method for the production of a protein preparation, which contains excipients and at least one therapeutic protein. In this case, the method includes subsequent stages of: (a) provision of a solution including the specified protein; (b) concentration of protein in the solution, using the first ultrafiltration stage; (c) diafiltration of the resulting solution with a buffer for diafiltration, which includes at least one first excipient, by means of which retentate including protein and the first excipient is obtained, while the first excipient is amino acid; (d) addition of the second excipient to retentate obtained at the diafiltration stage, while the second excipient is sugar; (e) subsequent concentration of protein in retentate at the second ultrafiltration stage in ultrafiltration equipment; and (f) addition of at least one final excipient, by means of which a protein preparation with the required concentration of protein is obtained, which includes the specified first and final excipients. At the same time, the final excipient is selected from a surfactant or a chelating agent, or any combination thereof. In this case, amino acid is histidine; the surfactant is polysorbate 80; the chelating agent is EDTA.
EFFECT: invention provides for a possibility of obtaining higher concentrations of proteins in the final composition, not affecting the yield and stability of protein.
28 cl, 24 tbl, 2 ex, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
ANTIBODY CONTAINING PREPARATION | 2017 |
|
RU2748046C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODIES TO PCSK-9, AND ITS USE | 2018 |
|
RU2782792C2 |
COMPOSITION CONTAINING ANTIBODY | 2019 |
|
RU2806628C2 |
COMBINATION PREPARATIONS WITH CYTOKINE ANTAGONIST AND CORTICOSTEROID | 2010 |
|
RU2526161C2 |
MUTATIONS IN OAS1 GENES | 2006 |
|
RU2465328C2 |
PROTEIN COMPOSITIONS AGAINST VEGF AND METHODS FOR THEIR PREPARATION | 2020 |
|
RU2788949C1 |
PROTEIN COMPOSITIONS AGAINST VEGF AND METHODS FOR THEIR PRODUCTION | 2020 |
|
RU2795973C1 |
COMBINED COMPOSITION CONTAINING FGF-18 COMPOUND | 2016 |
|
RU2745453C2 |
METHODS OF OBTAINING, PURIFICATION AND COMPOSING OF ANTIBODY-DRUG CONJUGATES | 2019 |
|
RU2801229C2 |
ANTIGEN-BINDING MOLECULE CAPABLE OF MULTIPLE BINDING TO A VARIETY OF ANTIGEN MOLECULES | 2018 |
|
RU2757786C2 |
Authors
Dates
2022-09-06—Published
2016-09-08—Filed